S&P 500   5,078.15 (+0.32%)
DOW   37,977.79 (+0.64%)
QQQ   431.17 (+0.03%)
AAPL   169.34 (-1.94%)
MSFT   415.85 (+0.53%)
META   500.32 (+0.02%)
GOOGL   154.60 (-0.17%)
AMZN   183.45 (-0.09%)
TSLA   155.93 (-3.44%)
NVDA   872.75 (+1.48%)
AMD   163.06 (+1.71%)
NIO   3.83 (-1.54%)
BABA   70.07 (-0.78%)
T   16.01 (-1.42%)
F   12.17 (-0.49%)
MU   120.96 (-0.34%)
GE   155.50 (+1.17%)
CGC   6.79 (-2.72%)
DIS   113.88 (+0.82%)
AMC   2.84 (+14.98%)
PFE   25.78 (-0.50%)
PYPL   63.70 (+0.30%)
XOM   118.37 (-1.09%)
S&P 500   5,078.15 (+0.32%)
DOW   37,977.79 (+0.64%)
QQQ   431.17 (+0.03%)
AAPL   169.34 (-1.94%)
MSFT   415.85 (+0.53%)
META   500.32 (+0.02%)
GOOGL   154.60 (-0.17%)
AMZN   183.45 (-0.09%)
TSLA   155.93 (-3.44%)
NVDA   872.75 (+1.48%)
AMD   163.06 (+1.71%)
NIO   3.83 (-1.54%)
BABA   70.07 (-0.78%)
T   16.01 (-1.42%)
F   12.17 (-0.49%)
MU   120.96 (-0.34%)
GE   155.50 (+1.17%)
CGC   6.79 (-2.72%)
DIS   113.88 (+0.82%)
AMC   2.84 (+14.98%)
PFE   25.78 (-0.50%)
PYPL   63.70 (+0.30%)
XOM   118.37 (-1.09%)
S&P 500   5,078.15 (+0.32%)
DOW   37,977.79 (+0.64%)
QQQ   431.17 (+0.03%)
AAPL   169.34 (-1.94%)
MSFT   415.85 (+0.53%)
META   500.32 (+0.02%)
GOOGL   154.60 (-0.17%)
AMZN   183.45 (-0.09%)
TSLA   155.93 (-3.44%)
NVDA   872.75 (+1.48%)
AMD   163.06 (+1.71%)
NIO   3.83 (-1.54%)
BABA   70.07 (-0.78%)
T   16.01 (-1.42%)
F   12.17 (-0.49%)
MU   120.96 (-0.34%)
GE   155.50 (+1.17%)
CGC   6.79 (-2.72%)
DIS   113.88 (+0.82%)
AMC   2.84 (+14.98%)
PFE   25.78 (-0.50%)
PYPL   63.70 (+0.30%)
XOM   118.37 (-1.09%)
S&P 500   5,078.15 (+0.32%)
DOW   37,977.79 (+0.64%)
QQQ   431.17 (+0.03%)
AAPL   169.34 (-1.94%)
MSFT   415.85 (+0.53%)
META   500.32 (+0.02%)
GOOGL   154.60 (-0.17%)
AMZN   183.45 (-0.09%)
TSLA   155.93 (-3.44%)
NVDA   872.75 (+1.48%)
AMD   163.06 (+1.71%)
NIO   3.83 (-1.54%)
BABA   70.07 (-0.78%)
T   16.01 (-1.42%)
F   12.17 (-0.49%)
MU   120.96 (-0.34%)
GE   155.50 (+1.17%)
CGC   6.79 (-2.72%)
DIS   113.88 (+0.82%)
AMC   2.84 (+14.98%)
PFE   25.78 (-0.50%)
PYPL   63.70 (+0.30%)
XOM   118.37 (-1.09%)
Free Trial
ASX:IRX

InhaleRx (IRX) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)
Free IRX Stock Alerts
Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About InhaleRx

InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. Its solutions include Medihale inhaler, a sealed pod inhaler for use with inhaled formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.

IRX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive IRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InhaleRx and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:IRX
CUSIP
N/A
CIK
N/A
Web
inhalerx.com.au
Phone
61 2 8072 1400
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-1,440,000.00
Net Margins
-119.87%
Pretax Margin
N/A
Return on Equity
-112.39%
Return on Assets
-46.40%

Debt

Debt-to-Equity Ratio
84.19
Current Ratio
1.73
Quick Ratio
5.69

Sales & Book Value

Annual Sales
$1.20 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
189,770,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
-0.83
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Darryl Davies B.Sc.
    Chief Executive Officer
  • Dr. Robert Jenny B.A.
    B.Sc., Ph.D., Chief Scientific Officer
  • Mr. Srinivasa Rao Suryadevara (Age 56)
    Executive Vice President
  • Mr. James Stephen Barrie CPA
    Company Secretary

Key Competitors

View All Competitors

Insiders


This page (ASX:IRX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Options trading has suddenly become more reliable.
Eagle Publishing
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press